129 related articles for article (PubMed ID: 31439257)
1. Value of normalized apparent diffusion coefficients in differentiating between borderline and malignant epithelial ovarian tumors.
Lu J; Pi S; Ma FH; Zhao SH; Li HM; Cai SL; Qiang JW
Eur J Radiol; 2019 Sep; 118():44-50. PubMed ID: 31439257
[TBL] [Abstract][Full Text] [Related]
2. Diffusion kurtosis imaging for differentiating borderline from malignant epithelial ovarian tumors: A correlation with Ki-67 expression.
Li HM; Zhao SH; Qiang JW; Zhang GF; Feng F; Ma FH; Li YA; Gu WY
J Magn Reson Imaging; 2017 Nov; 46(5):1499-1506. PubMed ID: 28295854
[TBL] [Abstract][Full Text] [Related]
3. Diffusion-weighted MR imaging for differentiating borderline from malignant epithelial tumours of the ovary: pathological correlation.
Zhao SH; Qiang JW; Zhang GF; Ma FH; Cai SQ; Li HM; Wang L
Eur Radiol; 2014 Sep; 24(9):2292-9. PubMed ID: 24871335
[TBL] [Abstract][Full Text] [Related]
4. The enhanced T
Han X; Sun M; Wang M; Fan R; Chen D; Xie L; Liu A
Eur J Radiol; 2019 Sep; 118():187-193. PubMed ID: 31439240
[TBL] [Abstract][Full Text] [Related]
5. Quantitative analysis of the MRI features in the differentiation of benign, borderline, and malignant epithelial ovarian tumors.
Xiao F; Zhang L; Yang S; Peng K; Hua T; Tang G
J Ovarian Res; 2022 Jan; 15(1):13. PubMed ID: 35062992
[TBL] [Abstract][Full Text] [Related]
6. Histogram Analysis Comparison of Monoexponential, Advanced Diffusion-Weighted Imaging, and Dynamic Contrast-Enhanced MRI for Differentiating Borderline From Malignant Epithelial Ovarian Tumors.
He M; Song Y; Li H; Lu J; Li Y; Duan S; Qiang J
J Magn Reson Imaging; 2020 Jul; 52(1):257-268. PubMed ID: 31922327
[TBL] [Abstract][Full Text] [Related]
7. MRI features and score for differentiating borderline from malignant epithelial ovarian tumors.
Li YA; Qiang JW; Ma FH; Li HM; Zhao SH
Eur J Radiol; 2018 Jan; 98():136-142. PubMed ID: 29279152
[TBL] [Abstract][Full Text] [Related]
8. Application of contrast-enhanced dual-energy spectral CT for differentiating borderline from malignant epithelial ovarian tumours.
Han X; Li B; Sun M; Li J; Li Y; Liu A
Clin Radiol; 2021 Aug; 76(8):585-592. PubMed ID: 34059294
[TBL] [Abstract][Full Text] [Related]
9. Multiparametric MRI for differentiation of borderline ovarian tumors from stage I malignant epithelial ovarian tumors using multivariate logistic regression analysis.
Denewar FA; Takeuchi M; Urano M; Kamishima Y; Kawai T; Takahashi N; Takeuchi M; Kobayashi S; Honda J; Shibamoto Y
Eur J Radiol; 2017 Jun; 91():116-123. PubMed ID: 28629557
[TBL] [Abstract][Full Text] [Related]
10. Texture Analysis of Three-Dimensional MRI Images May Differentiate Borderline and Malignant Epithelial Ovarian Tumors.
Ye R; Weng S; Li Y; Yan C; Chen J; Zhu Y; Wen L
Korean J Radiol; 2021 Jan; 22(1):106-117. PubMed ID: 32932563
[TBL] [Abstract][Full Text] [Related]
11. Apparent diffusion coefficients measured using different regions of interest in differentiating borderline from malignant ovarian tumors.
Lu JJ; Pi S; Ma FH; Zhang GF; Wei Qiang J
Acta Radiol; 2019 Aug; 60(8):1020-1027. PubMed ID: 30335478
[No Abstract] [Full Text] [Related]
12. Diagnostic efficacy of combining diffusion-weighted magnetic resonance imaging with serum Mucin 1, Mucin 13, and Mucin 16 in distinguishing borderline from malignant epithelial ovarian tumors.
Wen XT; Qiu HF; Ying LL; Huang M; Xiao YZ; Fan CC
Asia Pac J Clin Oncol; 2024 Jan; ():. PubMed ID: 38221766
[TBL] [Abstract][Full Text] [Related]
13. Apparent diffusion coefficient (ADC) measurement in ovarian tumor: Effect of region-of-interest methods on ADC values and diagnostic ability.
Mukuda N; Fujii S; Inoue C; Fukunaga T; Tanabe Y; Itamochi H; Ogawa T
J Magn Reson Imaging; 2016 Mar; 43(3):720-5. PubMed ID: 26201495
[TBL] [Abstract][Full Text] [Related]
14. Comparison between borderline ovarian tumors and carcinomas using semi-automated histogram analysis of diffusion-weighted imaging: focusing on solid components.
Mimura R; Kato F; Tha KK; Kudo K; Konno Y; Oyama-Manabe N; Kato T; Watari H; Sakuragi N; Shirato H
Jpn J Radiol; 2016 Mar; 34(3):229-37. PubMed ID: 26798066
[TBL] [Abstract][Full Text] [Related]
15. Combined use of CA125, neutrophil/lymphocyte ratio and platelet/lymphocyte ratio for the diagnosis of borderline and malignant epithelial ovarian tumors.
Huang K; Xu S; Wang J; Ge L; Xu J; Jia X
J Ovarian Res; 2023 Feb; 16(1):37. PubMed ID: 36759870
[TBL] [Abstract][Full Text] [Related]
16. Multiple instance convolutional neural network with modality-based attention and contextual multi-instance learning pooling layer for effective differentiation between borderline and malignant epithelial ovarian tumors.
Jian J; Xia W; Zhang R; Zhao X; Zhang J; Wu X; Li Y; Qiang J; Gao X
Artif Intell Med; 2021 Nov; 121():102194. PubMed ID: 34763809
[TBL] [Abstract][Full Text] [Related]
17. Application of apparent diffusion coefficient and exponent apparent diffusion coefficient values in magnetic resonance imaging diffusion-weighted imaging to differentiate benign and malignant ovarian epithelial tumors.
Wang YX; Yuan MZ; Wen ZX
J Cancer Res Ther; 2016; 12(1):401-5. PubMed ID: 27072270
[TBL] [Abstract][Full Text] [Related]
18. Utility of DWI with quantitative ADC values in ovarian tumors: a meta-analysis of diagnostic test performance.
Pi S; Cao R; Qiang JW; Guo YH
Acta Radiol; 2018 Nov; 59(11):1386-1394. PubMed ID: 29463093
[TBL] [Abstract][Full Text] [Related]
19. The serum CA-125 concentration data assists in evaluating CT imaging information when used to differentiate borderline ovarian tumor from malignant epithelial ovarian tumors.
Shin JE; Choi HJ; Kim MH; Cho KS
Korean J Radiol; 2011; 12(4):456-62. PubMed ID: 21852906
[TBL] [Abstract][Full Text] [Related]
20. Diffusion Weighted Imaging for Differentiating Benign from Malignant Orbital Tumors: Diagnostic Performance of the Apparent Diffusion Coefficient Based on Region of Interest Selection Method.
Xu XQ; Hu H; Su GY; Liu H; Shi HB; Wu FY
Korean J Radiol; 2016; 17(5):650-6. PubMed ID: 27587953
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
